Impairment of ceramide synthesis causes a novel progressive myoclonus epilepsy

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Annals of Neurology

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ana.24170PMID 24782409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endoplasmic reticulum dysfunction in neurological disease.

  2013cited by this paper
• The unfolded protein response: controlling cell fate decisions under ER stress and beyond

  2012influential reference
• Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy

  2012cited by this paper
• Sphingolipids: critical players in Alzheimer's disease.

  2012cited by this paper
• CLN5 and CLN8 protein association with ceramide synthase: Biochemical and proteomic approaches

  2012cited by this paper
• Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1.

  2012cited by this paper
• Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress

  2011cited by this paper
• A Deficiency of Ceramide Biosynthesis Causes Cerebellar Purkinje Cell Neurodegeneration and Lipofuscin Accumulation

  2011cited by this paper
• Mice Lacking Major Brain Gangliosides Develop Parkinsonism

  2011cited by this paper
• Alteration of Ceramide Synthase 6/C16-Ceramide Induces Activating Transcription Factor 6-mediated Endoplasmic Reticulum (ER) Stress and Apoptosis via Perturbation of Cellular Ca2+ and ER/Golgi Membrane Network*

  2011cited by this paper
• Different early ER-stress responses in the CLN8(mnd) mouse model of neuronal ceroid lipofuscinosis.

  2011cited by this paper
• Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophies.

  2010cited by this paper
• Sphingolipids in Multiple Sclerosis

  2010cited by this paper
• Pathology and Current Treatment of Neurodegenerative Sphingolipidoses

  2010influential reference
• The autosomal recessively inherited progressive myoclonus epilepsies and their genes

  2009cited by this paper
• Description of a family with a novel progressive myoclonus epilepsy and cognitive impairment

  2009cited by this paper
• Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response.

  2009cited by this paper
• Multiplex real-time PCR for detection of deletions and duplications in dystrophin gene.

  2006cited by this paper
• Necessary Role for the Lag1p Motif in (Dihydro)ceramide Synthase Activity*

  2006cited by this paper
• Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case study

  2005cited by this paper
• Upstream of Growth and Differentiation Factor 1 (uog1), a Mammalian Homolog of the Yeast Longevity Assurance Gene 1 (LAG1), RegulatesN-Stearoyl-sphinganine (C18-(Dihydro)ceramide) Synthesis in a Fumonisin B1-independent Manner in Mammalian Cells*

  2002cited by this paper
• Biology of oligodendrocyte and myelin in the mammalian central nervous system.

  2001cited by this paper
• No Evidence of a Major Locus for Benign Familial Infantile Convulsions on Chromosome 19q12‐q13.1

  1999cited by this paper

• Exercise improves depressive-like behavior in adolescent mice by regulating sphingosine and ceramide metabolism through microglial CerS1

  2025cites this paper
• Dietary Interventions Targeting the Neurolipidome in Epilepsy: From Preclinical Models to Clinical Applications and Future Therapeutic Approaches.

  2025influential citation
• Transcriptomic analyses of human brains with Alzheimer's disease identified dysregulated epilepsy-causing genes.

  2025cites this paper
• A CGG Repeat Expansion in CSNK1E Associated with Progressive Myoclonic Epilepsy with Incomplete Penetrance

  2025cites this paper
• Acid Ceramidase Deficiency

  2025cites this paper
• Individual lipid alterations at the origin of neuronal Ceramide Synthase defects

  2025cites this paper
• Fundamental Neurochemistry Review: Sphingolipids and Ceramides in Brain Development

  2025cites this paper
• Transcriptomic analyses of human brains with Alzheimer’s disease identified dysregulated epilepsy-causing genes

  2025cites this paper
• Multi-omics reveals that genes linked to succinylation regulate the onset of epilepsy through metabolic reprogramming

  2025cites this paper
• Human genetic defects of sphingolipid synthesis

  2024cites this paper
• Lipid Disbalance Affects Neuronal Dendrite Growth and Maintenance in a Human Ceramide Synthase Disease Model

  2024cites this paper
• Development of a Multiplexed Sphingolipids Method for Diagnosis of Inborn Errors of Ceramide Metabolism.

  2024cites this paper
• The Current Landscape in the Development of Small-molecule Modulators Targeting Sphingosine-1-phosphate Receptors to Treat Neurodegenerative Diseases.

  2024cites this paper
• Structural basis of the mechanism and inhibition of a human ceramide synthase

  2023cites this paper
• Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease

  2023cites this paper
• ASAH1 Variants Causing Spinal Muscular Atrophy Phenotype

  2023cites this paper
• Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells

  2023cites this paper
• Emerging roles and therapeutic potentials of sphingolipids in pathophysiology --emphasis on fatty acyl heterogeneity.

  2023cites this paper
• The ceramide synthase (CERS/LASS) family: Functions involved in cancer progression

  2023cites this paper
• Neuronal Ganglioside and Glycosphingolipid (GSL) Metabolism and Disease : Cascades of Secondary Metabolic Errors Can Generate Complex Pathologies (in LSDs).

  2023cites this paper
• Progressive myoclonic epilepsies—English Version

  2022cites this paper
• Progressive Myoklonusepilepsien

  2022cites this paper
• Diterpenoid DGA induces apoptosis via endoplasmic reticulum stress caused by changes in glycosphingolipid composition and inhibition of STAT3 in glioma cells.

  2022cites this paper
• The synaptic lipidome in health and disease.

  2022cites this paper
• The sphingolipid anteome: implications for evolution of the sphingolipid metabolic pathway

  2022cites this paper
• You aren't IMMUNE to the ceramides that accumulate in cardiometabolic disease.

  2022cites this paper
• Disorders of Complex Lipids

  2022cites this paper
• The Urinary Bladder is Rich in Glycosphingolipids Composed of Phytoceramides

  2022cites this paper
• Journal Pre-proof is Rich in Glycosphingolipids Composed of Phytoceramides

  2022cites this paper
• Accurate prediction of protein structures and interactions using a 3-track neural network

  2021cites this paper
• Interplay between ceramides and phytonutrients: New insights in metabolic syndrome

  2021cites this paper
• Dihydroceramide desaturase regulates the compartmentalization of Rac1 for neuronal oxidative stress.

  2021cites this paper
• FAM57B is a modulator of ceramide synthesis that regulates sphingolipid homeostasis and synaptic composition in the developing brain

  2021cites this paper
• Metabolic Dysfunction in Spinal Muscular Atrophy

  2021cites this paper
• Progressive Myoclonus Epilepsies

  2021cites this paper
• Inherited disorders of complex lipid metabolism: A clinical review

  2021cites this paper
• The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy

  2021cites this paper
• Clinical overview and phenomenology of movement disorders

  2021cites this paper
• 16pdel lipid changes in iPSC-derived neurons and function of FAM57B in lipid metabolism and synaptogenesis

  2021cites this paper
• Bioactive lipids and their metabolism, function, and sources

  2021cites this paper
• Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration.

  2021cites this paper
• Progressive myoclonus epilepsies-Residual unsolved cases have marked genetic heterogeneity including dolichol-dependent protein glycosylation pathway genes.

  2021cites this paper
• Clinical and molecular characterization of Unverricht–Lundborg disease among Egyptian patients

  2021cites this paper
• Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities

  2020cites this paper
• Molecular mechanisms of selective autophagy in Drosophila.

  2020cites this paper
• Advances in genetic testing and optimization of clinical management in children and adults with epilepsy

  2020cites this paper
• Untargeted lipidomic analysis of human hippocampus for temporal lobe epilepsy with hippocampal sclerosis.

  2020cites this paper
• Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content

  2020cites this paper
• Vitamin D3 Supplementation Increases Long-Chain Ceramide Levels in Overweight/Obese African Americans: A Post-Hoc Analysis of a Randomized Controlled Trial

  2020cites this paper
• Dihydroceramide desaturase regulates the compartmentalization of Rac1 for neuronal oxidative stress

  2020cites this paper
• Ceramide signalling in inherited and multifactorial brain metabolic diseases.

  2020cites this paper
• Ceramide synthase TLCD3B is a novel gene associated with human recessive retinal dystrophy

  2020cites this paper
• Downregulation of ceramide synthase 1 promotes oral cancer through endoplasmic reticulum stress

  2020cites this paper
• A perilous path: the inborn errors of sphingolipid metabolism

  2019cites this paper
• The Link between Gaucher Disease and Parkinson’s Disease Sheds Light on Old and Novel Disorders of Sphingolipid Metabolism

  2019cites this paper
• In Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism

  2019cites this paper
• In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism

  2019cites this paper
• Ceramides as Novel Disease Biomarkers.

  2019cites this paper
• DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans

  2019cites this paper
• Inherited monogenic defects of ceramide metabolism: Molecular bases and diagnoses.

  2019cites this paper
• Ceramide synthases in cancer therapy and chemoresistance.

  2019cites this paper
• Ceramide synthases in cancer therapy and chemoresistance.

  2019cites this paper
• Ganglioside Metabolism in Health and Disease.

  2018cites this paper
• Aberrant DEGS1 sphingolipid metabolism impairs central and peripheral nervous system function in humans

  2018cites this paper
• Sphingolipidoses and Related Disorders

  2018cites this paper
• Progressive Myoclonic Epilepsy Type 8 Due to CERS1 Deficiency: A Novel Mutation with Prominent Ataxia

  2018influential citation
• Sphingoid bases and their involvement in neurodegenerative diseases.

  2018cites this paper
• Unravelling the genetic architecture of autosomal recessive epilepsy in the genomic era

  2018cites this paper
• A proposed nosology of inborn errors of metabolism

  2018cites this paper
• Emerging concepts of ganglioside metabolism

  2018cites this paper
• Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities.

  2017cites this paper
• Overexpression of ceramide synthase 1 increases C18-ceramide and leads to lethal autophagy in human glioma

  2017cites this paper
• Crosstalk between sphingolipids and vitamin D3: potential role in the nervous system

  2017cites this paper
• The 16 p 11 . 2 homologs fam 57 ba and doc 2 a generate certain brain and body phenotypes

  2017cites this paper
• Lipophagy prevents activity‐dependent neurodegeneration due to dihydroceramide accumulation in vivo

  2017cites this paper
• The 16p11.2 homologs fam57ba and doc2a generate certain brain and body phenotypes

  2017cites this paper
• Sphingolipids and their metabolism in physiology and disease

  2017cites this paper
• De novo Synthesis of Sphingolipids Is Defective in Experimental Models of Huntington's Disease

  2017influential citation
• Sphingosine‐1‐phosphate receptor therapies: Advances in clinical trials for CNS‐related diseases

  2017cites this paper
• Enzyme Activities of the Ceramide Synthases CERS2–6 Are Regulated by Phosphorylation in the C-terminal Region*

  2016cites this paper
• Spinal muscular atrophy associated with progressive myoclonus epilepsy.

  2016cites this paper
• Unverricht-Lundborg disease.

  2016cites this paper
• Autosomal recessive progressive myoclonus epilepsy due to impaired ceramide synthesis.

  2016cites this paper
• Ectopic expression of ceramide synthase 2 in neurons suppresses neurodegeneration induced by ceramide synthase 1 deficiency

  2016cites this paper
• Genetic investigations of the epileptic encephalopathies: Recent advances.

  2016cites this paper
• An integrated analysis tool for analyzing hybridization intensities and genotypes using new-generation population-optimized human arrays

  2016cites this paper
• Advancing epilepsy genetics in the genomic era

  2015cites this paper
• Genetic Counselling in Epilepsy

  2015cites this paper
• Epilepsy genetics: the ongoing revolution.

  2015cites this paper
• Human genetic disorders of sphingolipid biosynthesis

  2015cites this paper
• Monogenic neurological disorders of sphingolipid metabolism.

  2015cites this paper
• CHARACTERIZATION OF CELLULAR AND MOLECULAR MECHANISMS IN CELLULAR MODELS OF NEURONAL CEROID LIPOFUSCINOSES DISEASES

  2015cites this paper
• Ceramide center stage in progressive myoclonus epilepsies

  2014cites this paper